Back to results
US 8,278,308 B2Granted
Diketopiperazine salts for drug delivery and related methods
AssigneeMannKind Corporation
InventorsAndrea Leone-Bay, Destardi Moye-Sherman, Bryan R. Wilson
Life of this patent
Estimating the term…
Abstract
Drug delivery systems have been developed based on the formation of diketopiperazine carboxylate salts and microparticles containing the same. The systems may further comprise a bioactive agent. Related methods for making and using the biologically active agent delivery compositions are also provided. In certain embodiments, the pharmaceutically acceptable salts described can be formed by removal of solvent by methods including distillation, evaporation, spray drying or lyophilization.
Claims14
A method for delivery of a biologically active agent comprising:
- administering to a patient in need of treatment therewith an effective amount of a biologically active agent in the form of microparticles, said microparticles comprising a pharmaceutically acceptable salt of a diketopiperazine and the biologically active agent;
- wherein said microparticles release said biologically active agent upon administration;
- and
- wherein said pharmaceutically acceptable salt of the diketopiperazine has the structure according to Formula 1:
- wherein Formula 1 is a diketopiperazine selected from the following compounds:
- 3,6-di(4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(succinyl-4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(maleyl-4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(citraconyl-4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(glutaryl-4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(malonyl-4-aminobutyl)-2,5-diketopiperazine,
- 3,6-di(oxalyl-4-aminobutyl)-2,5-diketopiperazine, and
- 3,6-di(fumaryl-4-aminobutyl)-2,5-diketopiperazine;
- and
- said salt further comprises at least one cation.
12 more elements
Dependencies are inferred from the claim text.